Silymarin for the Prevention of Atrial Fibrillation After Cardiac Surgery

Summary

The study is a prospective, randomized, controlled trial to assess the effects of silymarin on the occurrence of postoperative atrial fibrillation after coronary artery bypass graft surgery.

Timeline

Start

2023-01-01

Primary completion

2024-09-01

Completion

2024-09-30

Drugs

Indications